Latest News

Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature's Miracle ("NMHI") Common Stocks

ONTARIO, Calif., July 28, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology announce that Big Lake Capital, LLC (the "Investor"), an investment company led and controlled by CEO Tie "James" Li, converted$678,29...

2025-07-28 20:30 2953

World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market

SUZHOU, China, July 28, 2025 /PRNewswire/ -- ImmVira Group ("ImmVira" or the "Company")recently announced that its engineered exosome products MVR-EX104 ("EX104", for alopecia treatment) and MVR-EX105 ("EX105", for localized fat accumulation) have obtained International Nomenclature of Cosmetic I...

2025-07-28 20:28 2826

CreateAI, a Leader in Applied AI Technology, Launches Animon.ai Studio Version for Creators to Make Their Own Anime Series

Animon Studio Makes Professional Anime Creation and Storytelling Accessible to All TOKYO, July 28, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") (OTC: TSPH), a leader in applied artificial intelligence technology, today announced the launch of the Studio Version of Animon....

2025-07-28 20:00 4034

CHINA YUCHAI INTERNATIONAL TO ANNOUNCE UNAUDITED 2025 FIRST-HALF YEAR FINANCIAL RESULTS ON AUGUST 8, 2025

- Earnings Call to Begin at 8:00 A.M. EDT – SINGAPORE, July 28, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), announced today that it will be releasing its 2025 unaudited first-half year financial results onFriday, August 8, 2025 before t...

2025-07-28 19:45 5164

Daqo New Energy Issues Its 2024 Environmental, Social and Governance (ESG) Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today published its 2024 Environmental, Social and Governance ("ESG") report.  The 2024 ESG rep...

2025-07-28 19:00 3042

2025 World Internet Conference Digital Silk Road Development Forum Opens in Quanzhou

QUANZHOU, China, July 28, 2025 /PRNewswire/ -- A news report from CRI Online: The opening ceremony of the Digital Silk Road Development Forum of the 2025 World Internet Conference O...

2025-07-28 18:45 2013

Quhuo Partners with NIU World to Launch Innovative Fresh Beef Chain Brand Incubation Platform, Accelerating the Transformation of China's Fresh Beef Consumption Market

BEIJING, July 28, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading tech-enabled service platform, today announced a strategic partnership with NIU World, a local food group inChina, to jointly establish a new chain brand incubation platform focused on fresh be...

2025-07-28 18:00 2578

Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat

* CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is expected to begin in the U.S. andCanada in Q3 2025. * CBL-514 is the first 505(b)(1) inve...

2025-07-28 17:51 2131

FinVolution Group Publishes Seventh Annual ESG Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced it has released its 2024 Environmental, Social, and Governance (ESG) report, the Company's seventh consecutive annual ESG report. The report provid...

2025-07-28 17:30 2410

Cheetah Mobile to Acquire Controlling Stake in UFACTORY to Accelerate Its Robotics Commercialization Strategy

BEIJING, July 28, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), aChina-based IT company, today announced that one of its majority-owned subsidiaries has signed a definitive agreement to acquire an equity interest of 60.8% in Shenzhen UFACTORY Technolog...

2025-07-28 17:00 2621

Last Chance to Get COSRX's Best-Selling Snail Duo on the House at Alfred Coffee -- This Wednesday Only

LOS ANGELES, July 28, 2025 /PRNewswire/ -- It's the glow-up everyone's been talking about. This July, cult K-beauty favoriteCOSRX joined forces with LA's iconic café Alfred Coffee ...

2025-07-28 16:49 2252

Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader

— Acquires 89.59% stake in U.S. automation engineering firm ONExia — Strengthens future growth engine with AI•humanoid technology•top-tier talent and builds an R&D Innovation center EXTON, Pa. and SEONGNAM, South Korea, July 28, 2025 /PRNewswire/ -- Doosan Robotics is stepping up its transformati...

2025-07-28 16:10 1932

Beijing Review: The Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program concluded in Shanghai.

BEIJING, July 28, 2025 /PRNewswire/ -- On July 22, the Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program officially came to a close inShanghai.   The story never ends! On July 22, the Across the Pacific: China-#US Youth Dialogue for a Shared Future pr...

2025-07-28 15:45 1889

The 2025 China-ASEAN Education Cooperation Week Held in Guizhou

GUIYANG, China, July 28, 2025 /PRNewswire/ -- This is a report from Discover Guizhou: On July 26, the opening ceremony of the 2025 China-ASEAN Education Cooperation Week (CAECW) was held at the permanent venue of the China-ASEAN Education Cooperation Week in Gui'an New Area,Guiyang, Guizhou. The...

2025-07-28 15:28 1783

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'

* CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea® * Upon approval, EYLUXVI® will be Alteogen's second biosimilar product, following a Herceptin® biosimilar by Alteogen's license partner Qilu Pharm...

2025-07-28 14:00 2702

DIGITIMES ASIA: Nvidia explores SOCAMM deployment for next-gen AI systems

TAIPEI, July 23, 2025 /PRNewswire/ -- Nvidia is preparing to enter a new phase in the memory market by planning to deploy between 600,000 and 800,000 SOCAMM modules in 2025. This initiative positions SOCAMM as a potential successor to high-bandwidth memory (HBM). Although the initial deployment v...

2025-07-28 13:02 3740

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New Drug Application (sNDA) for ivonescimab (PD-1/VEGF bispecific antibody) in combination with ...

2025-07-28 12:14 3697

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30

-          First participants with obesity or overweight with at least one w eight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1  receptor agonist ASC30. -          Ultra-long-acting SQ depot for...

2025-07-28 08:15 2255

Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive prof...

2025-07-28 08:11 2482

Breakthrough in Light Therapy: KouShiCare utilizes DWV™LLLT Technology to Treat Dry Eyes

HONG KONG, July 27, 2025 /PRNewswire/ -- KouShiCare, a leading innovator in healthcare technology, is proud to announce a groundbreaking advancement in the treatment of dry eye disease. The company's latest device harnesses the power of DWV™ Low-Level Laser Therapy (LLLT) technology, marking a si...

2025-07-27 23:07 3562

Week's Top Stories